DNA adducts in humans after exposure to methylating agents.

Human exposure to methylating agents appears to be widespread, as indicated by the frequent occurrence of methylated DNA adducts in human DNA. The high incidence of methylated DNA adducts even in humans thought not to have suffered extensive exposure to environmental methylating agents implies that chemicals of endogenous origin, probably N-nitroso compounds such as the strongly carcinogenic N-nitrosodimethylamine (NDMA), may be primarily responsible for their formation and raises the question of the carcinogenic risks associated with such exposure. In addition to accumulation of DNA damage, other factors (such as induced cell proliferation) appear to be important in determining the probability of induction of mutation or cancer by NDMA, implying that high to low dose risk extrapolations should not be based on the assumption of dose- or even adduct-linearity. Comparative studies of the accumulation and repair of methylated adducts in humans and animals treated with methylating cytostatic drugs do not reveal significant species differences. Based on this and the dosimetry of adduct accumulation in rats chronically exposed to very low doses of NDMA, it is suggested that the exposure needed to account for the levels of adducts found in human DNA may be of the order of hundreds of micrograms NDMA (or equivalent) per day, a level of exposure which may well represent a significant carcinogenic hazard for man.

[1]  M. Takeshita,et al.  Mechanism of mutation on DNA templates containing synthetic abasic sites: study with a double strand vector. , 1994, Nucleic acids research.

[2]  S. Kyrtopoulos,et al.  Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine. , 1994, Carcinogenesis.

[3]  M. Anderson,et al.  Mutational specificity of N-nitrosodimethylamine: comparison between in vivo and in vitro assays. , 1993, Mutation research.

[4]  V. Souliotis,et al.  Accumulation of O6-methylguanine in human DNA after therapeutic exposure to methylating agents and its relationship with biological effects. , 1993, Environmental health perspectives.

[5]  D. Crowther,et al.  Relationships between the formation of O6-methyldeoxyguanosine by 1-p-carboxyl-3,3-dimethylphenyltriazene in DNA and O6-alkylguanine-DNA alkyltransferase in human peripheral leukocytes. , 1994, Cancer research.

[6]  H. Keizer,et al.  N7-Methylguanine and O(6)-methylguanine levels in DNA of white blood cells from cancer patients treated with dacarbazine. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[7]  Marshall W. Anderson,et al.  Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. , 1991, Carcinogenesis.

[8]  M. Hollstein,et al.  p53 mutations in esophageal tumors from high‐incidence areas of China , 1995, International journal of cancer.

[9]  L. Fong,et al.  DNA adduct dosimetry and DNA repair in rats and pigs given repeated doses of procarbazine under conditions of carcinogenicity and human cancer chemotherapy respectively. , 1992, Carcinogenesis.

[10]  K. Chang,et al.  p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas. , 1996, Carcinogenesis.

[11]  M. C. Archer,et al.  The role of hepatocyte heterogeneity in the initiation of hepatocarcinogenesis. , 1993, Carcinogenesis.

[12]  S. Sukumar,et al.  Frequent activation of the Ki‐ras oncogene at codon 12 in N‐methyl‐N‐nitrosourea‐induced rat prostate adenocarcinomas and neurogenic sarcomas , 1991, Molecular carcinogenesis.

[13]  M. Marletta.  Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. , 1988, Chemical Research in Toxicology.

[14]  S. Kyrtopoulos,et al.  Comparative study of mutagenesis by O6-methylguanine in the human Ha-ras oncogene in E. coli and in vitro. , 1994, Nucleic acids research.

[15]  C. S. Yang,et al.  Roles of cytochrome P450IIE1 in the dealkylation and denitrosation of N-nitrosodimethylamine and N-nitrosodiethylamine in rat liver microsomes. , 1990, Carcinogenesis.

[16]  T. Ishikawa,et al.  O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Watatani,et al.  Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats. , 1989, Cancer research.

[18]  P Grasso,et al.  Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. , 1991, Cancer research.

[19]  D. Beranek.  Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. , 1990, Mutation research.

[20]  D Hoffmann,et al.  The relevance of tobacco-specific nitrosamines to human cancer. , 1989, Cancer surveys.

[21]  V. Souliotis,et al.  Differential effects of procarbazine and methylnitrosourea on the accumulation of O6-methylguanine and the depletion and recovery of O6-alkylguanine-DNA alkyltransferase in rat tissues. , 1994, Carcinogenesis.

[22]  C. Wild,et al.  06‐Methyldeoxyguanosine in oesophageal dna among individuals at high risk of oesophageal cancer , 1985 .

[23]  S. Kyrtopoulos,et al.  Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. , 1990, Cancer research.

[24]  S. Preston‐Martin,et al.  Gliomas and meningiomas in men in Los Angeles County: investigation of exposures to N-nitroso compounds. , 1991, IARC scientific publications.

[25]  Z. Ronai,et al.  G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. , 1993, Carcinogenesis.

[26]  S. Preston‐Martin,et al.  Ras oncogene mutations in childhood brain tumors. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  P. I. Reed,et al.  N-nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite employing an improved analytical method. , 1993, Carcinogenesis.

[28]  B. Spiegelhalder,et al.  Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. , 1994, Carcinogenesis.

[29]  E. Bowman,et al.  Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. , 1995, Journal of the National Cancer Institute.

[30]  H. Schuller,et al.  DNA single-strand breaks and toxicity induced by 4-(methyl-nitrosamino)-1-(3- pyridyl)-1-butanone or N-nitrosodimethylamine in hamster and rat liver. , 1994, Carcinogenesis.

[31]  L. Hsieh,et al.  p53 mutations in gastric cancers from Taiwan. , 1996, Cancer letters.

[32]  M. C. Hu,et al.  Mutagenicity and mutational spectrum of N-methyl-N'-nitro-N-nitrosoguanidine in the hprt gene in G1-S and late S phase of diploid human fibroblasts. , 1993, Cancer research.

[33]  A. Badawi,et al.  Detection of O6-methylguanine in human DNA. , 1988, IARC scientific publications.

[34]  D. Cooper,et al.  Promutagenic methylation damage in bladder DNA from patients with bladder cancer associated with schistosomiasis and from normal individuals. , 1992, Carcinogenesis.

[35]  P Grasso,et al.  Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. , 1991, Cancer research.

[36]  D. Crowther,et al.  Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide. , 1994, British Journal of Cancer.

[37]  S. Kyrtopoulos,et al.  Comparative study of the formation and repair of O6-methylguanine in humans and rodents treated with dacarbazine. , 1996, Carcinogenesis.

[38]  A. Tates,et al.  Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  D. Thomas,et al.  Consumption of nitrate, nitrite, and nitrosodimethylamine and the risk of upper aerodigestive tract cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  H. Bartsch.  N-nitroso compounds and human cancer: where do we stand? , 1991, IARC scientific publications.

[41]  S. Hughes,et al.  Mutagenesis in Escherichia coli by three O6-substituted guanines in double-stranded or gapped plasmids. , 1995, Biochemistry.

[42]  S. Preston‐Martin,et al.  Maternal consumption of cured meats and vitamins in relation to pediatric brain tumors. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  T. Ushijima,et al.  Demonstration of ras and p53 Gene Mutations in Carcinomas in the Forestomach and Intestine and Soft Tissue Sarcomas Induced by N‐Methyl‐N‐nitrosourea in the Rat , 1997, Japanese journal of cancer research : Gann.

[44]  D. Cooper,et al.  Formation and loss of O6-methyldeoxyguanosine in human leucocyte DNA following sequential DTIC and fotemustine chemotherapy. , 1994, British Journal of Cancer.

[45]  Z Szmeja,et al.  Tobacco smoke-associated N7-alkylguanine in DNA of larynx tissue and leucocytes. , 1996, Carcinogenesis.

[46]  S. Hecht,et al.  Detection of O6-methyldeoxyguanosine in human placental DNA. , 1988, Cancer research.

[47]  S. Tannenbaum,et al.  Mechanisms of endogenous nitrosation. , 1989, Cancer surveys.

[48]  E. Chance,et al.  Kinetic analysis of the coding properties of O6-methylguanine in DNA: the crucial role of the conformation of the phosphodiester bond. , 1994, Biochemistry.

[49]  L. Anderson,et al.  Dosimetry of O6-methylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA). Implications for the mechanism of NDMA hepatocarcinogenesis. , 1995, Carcinogenesis.

[50]  H. Bartsch,et al.  Human exposure to endogenous N-nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder. , 1989, Cancer surveys.

[51]  D. Parkin,et al.  Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma , 1991, International journal of cancer.

[52]  L. Anderson,et al.  N‐nitrosodimethylamine‐derived O6‐methylguanine in DNA of monkey gastrointestinal and urogenital organs and enhancement by ethanol , 1996, International journal of cancer.

[53]  T. P. Pretlow,et al.  Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. , 1995, Carcinogenesis.

[54]  G. Bataille.  L'Abbé C , 1950 .

[55]  A. Axon,et al.  Mutagens, N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomach. , 1993, European journal of cancer.

[56]  S. Tannenbaum.  A model for estimation of human exposure to endogenous N-nitrosodimethylamine. , 1980, Oncology.

[57]  D. Wade,et al.  Concurrent generation of methylamine and nitrite during denitrosation of N-nitrosodimethylamine by rat liver microsomes. , 1987, Cancer research.

[58]  M. Stratton,et al.  Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. , 1995, Carcinogenesis.

[59]  H. Vrieling,et al.  Molecular analysis of hprt gene mutations in skin fibroblasts of rats exposed in vivo to N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea. , 1994, Cancer research.

[60]  J. Hotchkiss.  Preformed N-nitroso compounds in foods and beverages. , 1989, Cancer surveys.

[61]  K. Hemminki,et al.  Separation of 7-methyl- and 7-(2-hydroxyethyl)-guanine adducts in human DNA samples using a combination of TLC and HPLC. , 1996, Carcinogenesis.

[62]  S. Preston‐Martin,et al.  Prenatal exposure to tobacco smoke and childhood brain tumors: results from the United States West Coast childhood brain tumor study. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[63]  C. Weghorst,et al.  Mutations in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine , 1996 .

[64]  E. Newcomb,et al.  N‐methylnitrosourea—lnduced Ki‐ras codon 12 mutations: Early events in mouse thymic lymphomas , 1995, Molecular carcinogenesis.

[65]  C. Fan,et al.  Alkyltransferase transgenic mice: probes of chemical carcinogenesis. , 1994, Mutation research.

[66]  B. F. Li,et al.  The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgene. , 1995, Carcinogenesis.